.png?w=500&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=93E0AA22CECB08C974D7737276A90BA3)
Empowering biologics delivery
Unlocking future therapies
We're enabling drug delivery through high purity excipients and next generation lipids and adjuvants to tackle your solubility and stability challenges
We're developing the next generation of excipients for human and veterinary applications
Looking for something in particular? Search our broad portfolio here:
Products formulators love
We’re committed to investing in the next generation of excipients you need. Our teams work with you to troubleshoot formulations and develop research grade and GMP excipient solutions. Purity is our forte across our multi-compendial, GMP grade materials.
Explore by market:
Human and veterinary pharmaceuticals
Our purpose, Smart science to improve lives™, is at the core of our human and veterinary market strategy. We support the pharmaceutical market by developing high purity excipients which enhance delivery, efficacy, and stability of actives. We also manufacture industry leading high purity vaccine adjuvants and innovative lipids.
Consumer Health
Explore our excipients for the Consumer Health market that will aid in developing innovative products to meet changing consumer needs and market trends. Learn how we can help you grow your product brand by offering quality specialty ingredients developed for the OTC, oral hygiene, and human nutrition markets.
Decades of driving biopharma forward
Smart science to improve lives™
Your pharma solutions partner:
- High purity excipients: Optimising the performance of formulations to solve your stability and solubility challenges
- Vaccine adjuvants: Committed to the highest standards, with 80+ years of expertise in adjuvant research and development
- Innovative lipids: Enabling the delivery and stability of nucleic acid-based vaccines, therapeutics and gene editing technology.
We are committed to enabling the next generation of drug delivery systems, so by partnering with Croda Pharma, you are in safe hands.
The race to beat COVID-19
As COVID-19 surged across the world, our team fought against time to get critical materials ready for the worlds leading vaccines.
Watch the story unfold in our mini documentary.
Explore our latest articles:
SCIENTIFIC BLOG
Promising new results for metastatic prostate cancer vaccine
WEBINAR
Transforming oral drug delivery: new claims and features with our excipients
EXPERT WHITEPAPER
Lipid technology for gene-editing therapies
BLOG
Consumer Health - over 100 years of heritage
WHITEPAPER
Innovative lipids for your Nucleic Acid Delivery research
View our most recent blogs:
Spotlight on Kritika Bajaj
Highlighting the scientists and teams who are involved in our latest product launch, Virodex™, replacements for Triton™ X-100, we sat down with Kritika Bajaj and asked her about her involvement around...
Read more
Croda’s response to Sustainable Markets Initiative for supplier sustainability targets
The recent open letter from the Sustainable Markets Initiative Health Systems Task Force called for Healthcare supply chains to become greener, more efficient and circular and set out a series of...
Read more
Sustainability for vaccines: Decarbonisation of one of our key sites
Sustainability is often defined as meeting the needs of those alive today without compromising the ability of future generations to meet their needs. It is a long-term goal that covers three pillars:...
Read more
A powerful match - celebrating three years of Croda Pharma and Avanti
Today marks three years since we acquired Avanti Polar Lipids. During the COVID-19 pandemic, it became clear that the combination of Avanti's lipid expertise and our manufacturing scale-up capability...
Read more